10.10.26 -- Bioprocess Online Newsletter - September

Regulators expect cell therapy manufacturers to prove they control for visible particles, but guidance remains notably quiet on the matter. Companies must get creative or risk clinical holds.

AI algorithms can reduce data dimensionality more faithfully by interpreting multivariate features relevant to prediction or control.

In this opening segment from the Bioprocess Online Live event “Ensuring Successful Technology Transfer In ADC Development,” panelists Sourav Kundu, Ph.D., and Will Olughu, Ph.D., explain how ADC constructs complicate process and knowledge transfers compared to traditional biologics.

Explore chromatography techniques, media chemistries, system configurations, and practical applications used throughout bioprocess development and manufacturing.

Minimizing liquid dead volume helps labs conserve costly reagents and scarce samples while boosting assay throughput. Learn how advanced liquid level detection technologies are driving efficiency.

Discover how salt-active endonucleases overcome DNA clearance challenges in viral vector purification by digesting down to 3–5 nucleotides and performing reliably in high-salt conditions.